A new study presented at the UEG Week 2025 has found that both sugar-sweetened beverages (SSBs) and low- or no-sugar-sweetened beverages (LNSSBs) may significantly increase the risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). Contrary to the common belief that diet drinks are safer, the findings suggest that even modest intake of low- or no-sugar-sweetened beverages, such as a single can per day, may pose health risks.
To investigate how different beverages influence liver health , researchers from the UK Biobank study followed 123,788 participants without liver disease at baseline. Participants’ beverage intake was assessed through repeated 24-hour dietary questionnaires. Over a median